BioMarin sales and marketing update

BioMarin launched its Firdapse amifampridine in Germany and the U.K. to treat Lambert Eaton Myasthenic Syndrome (LEMS). In February, BioMarin said Firdapse will be sold at €23 ($30.96) per 10 mg tabl...